The DOI matches its Crossref record.
International Journal of Chronic Obstructive Pulmonary Disease
Open accessAbstract
The International Journal of Chronic Obstructive Pulmonary Disease Indexed:- American Chemical Society's Chemical Abstracts Service (CAS)- PubMed (files to appear soon)ISSN 1176-9106 (Print)ISSN 1178-2005 (Online)An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals. Key benefitsConcise rapid reportingFocus on improved management of COPDSubject areas include:Chronic bronchitis, emphysema, and irreversible or partially reversible progressive airway obstruction, as a result of chronic inflammation due to smoking or exposure to other toxic substances. Clinical and pharmacological studies throughout the drug development process on relevant compounds including bronchodilators (long- and short-acting), anticholinergics, theophylline, phosphodiesterase inhibitors, leukotriene receptor antagonists, cromoglicate and related therapies, inhaled and oral steroids, combination products, mucolytics, and alpha-1 antitrypsin replacementSpecific focus on delivery devices and optimal usagePrevalence, safety, outcome, health economic, and quality of life studiesSmoking cessation programsPalliative care and treatment of associated morbidities and complications, eg, anxiety and depressionUse of antibiotics, antivirals, and vaccination to treat/prevent exacerbationsEarly identification to facilitate preventionDisease management programs, and multidisciplinary team approachClinical guidelines, formulary management, and drug utilization reviewsCompliance, concordance, and persistency studiesPatient and care giver health education programs including patient self managementNon pharmacological interventions including pulmonary rehabilitation, physiotherapy, non-invasive ventilation, surgery.These areas are addressed through:Original clinical research (full papers and concise rapid reports)Reviews Basic science studies that shed light on disease pathogenesis or the mode of action of treatment modalitiesSystematic reviews of individual new or important drugs. Such reviews will normally be commissionedExpert opinion and commentary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bellan, M., Soddu, D., Balbo, P. E., Baricich, A., Zeppegno, P., Avanzi, G. C., Baldon, G., Bartolomei, G., Battaglia, M., Battistini, S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.36142 · Cited by 474
Wang, M., Aaron, C. P., Madrigano, J., Hoffman, E. A., Angelini, E., Yang, J., Laine, A., Vetterli, T. M., Kinney, P. L., Sampson, P. D., et al. (2019) · JAMA · doi:10.1001/jama.2019.10255 · Cited by 389
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Ma, X., Liu, Z., Ilyas, I., Little, P. J., Kamato, D., Sahebka, A., Chen, Z., Luo, S., Zheng, X., Weng, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59965 · Cited by 299
Bellou, V., Belbasis, L., Konstantinidis, A. K., Tzoulaki, I., & Evangelou, E. (2019) · BMJ · doi:10.1136/bmj.l5358 · Cited by 197
Akter, S., Islam, M. R., Rahman, M. M., Rouyard, T., Nsashiyi, R. S., Hossain, F., & Nakamura, R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.22341 · Cited by 57
Rebelo, P., Oliveira, A., Paixão, C., Valente, C., Andrade, L., & Marques, A. (2020) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s219480 · Cited by 37
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Singh, V., Ulasov, I., Gupta, S., Singh, A., Roy, V. K., & Kharwar, R. K. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436180.3 · Cited by 17
Al Sibani, M., Al Alawi, A., & Al Aghbari, J. (2022) · Sultan Qaboos University Medical Journal · doi:10.18295/squmj.8.2021.099 · Cited by 3
Metadata
- Venue
- International Journal of COPD
- Publisher
- Informa UK Limited
- Published
- 2020-03-15
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- DOI
- 10.2147/copd
- OpenAlex
- W4251855335
- Cited by
- 722
- References
- 0
- Type
- paratext
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.